Annual CFF
$5.02 M
+$5.00 M+17224.14%
31 December 2023
Summary:
Cyclerion Therapeutics annual cash flow from financing activities is currently $5.02 million, with the most recent change of +$5.00 million (+17224.14%) on 31 December 2023. During the last 3 years, it has fallen by -$23.07 million (-82.11%). CYCN annual CFF is now -97.63% below its all-time high of $211.57 million, reached on 31 December 2019.CYCN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
$0.000.00%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly cash flow from financing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.CYCN quarterly CFF is now -100.00% below its all-time high of $174.98 million, reached on 30 June 2019.CYCN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$0.00
$0.000.00%
30 September 2024
Summary:
Cyclerion Therapeutics TTM cash flow from financing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$5.04 million (-100.00%). CYCN TTM CFF is now -100.00% below its all-time high of $262.49 million, reached on 30 June 2019.CYCN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | 0.0% | -100.0% |
| 3 y3 years | -82.1% | -100.0% | -100.0% |
| 5 y5 years | -95.0% | -100.0% | -100.0% |
CYCN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -83.7% | >+9999.0% | -100.0% | -100.0% | ||
| 5 y | 5 years | -97.6% | >+9999.0% | -100.0% | -100.0% | ||
| alltime | all time | -97.6% | >+9999.0% | -100.0% | -100.0% |
Cyclerion Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2023 | $5.02 M(>+9900.0%) | $0.00(0.0%) | $5.02 M(-0.2%) |
| Sept 2023 | - | $0.00(-100.0%) | $5.04 M(0.0%) |
| June 2023 | - | $5.02 M(>+9900.0%) | $5.04 M(>+9900.0%) |
| Dec 2022 | $29.00 K(-99.9%) | $12.00 K(>+9900.0%) | $29.00 K(-71.6%) |
| Sept 2022 | - | $0.00(-100.0%) | $102.00 K(-29.7%) |
| June 2022 | - | $17.00 K(-80.0%) | $145.00 K(-99.5%) |
| Dec 2021 | $30.79 M(+9.6%) | $85.00 K(+97.7%) | $30.79 M(-0.2%) |
| Sept 2021 | - | $43.00 K(-99.9%) | $30.86 M(-44.0%) |
| June 2021 | - | $30.63 M(>+9900.0%) | $55.08 M(+95.9%) |
| Mar 2021 | - | $27.00 K(-83.0%) | $28.12 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $28.09 M(-86.7%) | $159.00 K(-99.3%) | $28.09 M(+0.0%) |
| Sept 2020 | - | $24.27 M(+562.5%) | $28.08 M(+572.6%) |
| June 2020 | - | $3.66 M(>+9900.0%) | $4.17 M(-97.6%) |
| Mar 2020 | - | $1000.00(-99.3%) | $175.49 M(-17.1%) |
| Dec 2019 | $211.57 M(+109.6%) | $145.00 K(-60.3%) | $211.57 M(-10.5%) |
| Sept 2019 | - | $365.00 K(-99.8%) | $236.39 M(-9.9%) |
| June 2019 | - | $174.98 M(+384.9%) | $262.49 M(+137.7%) |
| Mar 2019 | - | $36.09 M(+44.5%) | $110.44 M(+9.4%) |
| Dec 2018 | $100.94 M(+22.2%) | $24.97 M(-5.7%) | $100.94 M(+32.9%) |
| Sept 2018 | - | $26.46 M(+15.5%) | $75.97 M(+53.5%) |
| June 2018 | - | $22.92 M(-13.8%) | $49.51 M(+86.2%) |
| Mar 2018 | - | $26.59 M | $26.59 M |
| Dec 2017 | $82.62 M | - | - |
FAQ
- What is Cyclerion Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual CFF year-on-year change?
- What is Cyclerion Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly CFF year-on-year change?
- What is Cyclerion Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics TTM CFF year-on-year change?
What is Cyclerion Therapeutics annual cash flow from financing activities?
The current annual CFF of CYCN is $5.02 M
What is the all time high annual CFF for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual cash flow from financing activities is $211.57 M
What is Cyclerion Therapeutics annual CFF year-on-year change?
Over the past year, CYCN annual cash flow from financing activities has changed by +$5.00 M (+17224.14%)
What is Cyclerion Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CYCN is $0.00
What is the all time high quarterly CFF for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly cash flow from financing activities is $174.98 M
What is Cyclerion Therapeutics quarterly CFF year-on-year change?
Over the past year, CYCN quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Cyclerion Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CYCN is $0.00
What is the all time high TTM CFF for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high TTM cash flow from financing activities is $262.49 M
What is Cyclerion Therapeutics TTM CFF year-on-year change?
Over the past year, CYCN TTM cash flow from financing activities has changed by -$5.04 M (-100.00%)